|86.13||+0.0400||+0.05%||Vol 464.23K||1Y Perf 14.99%|
|Nov 30th, 2023 16:00 DELAYED|
|- -||-0.01 -0.01%|
|Target Price||93.67||Analyst Rating||Moderate Buy 1.75|
|Potential %||8.75||Finscreener Ranking||★★★ 48.45|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★ 51.13|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★+ 60.77|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★★★★ 54.14|
|Price Range Ratio 52W %||79.28||Earnings Rating||Strong Buy|
|Market Cap||10.20B||Earnings Date||16th Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||0.27|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||352.66K|
|Avg. Monthly Volume||462.43K|
|Avg. Quarterly Volume||369.13K|
Dolby Laboratories (NYSE: DLB) stock closed at 86.13 per share at the end of the most recent trading day (a 0.05% change compared to the prior day closing price) with a volume of 464.23K shares and market capitalization of 10.20B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Software industry, Technology sector and employs 2289 people. Dolby Laboratories CEO is Kevin J. Yeaman.
The one-year performance of Dolby Laboratories stock is 14.99%, while year-to-date (YTD) performance is 22.1%. DLB stock has a five-year performance of 22.34%. Its 52-week range is between 67.44 and 91.015, which gives DLB stock a 52-week price range ratio of 79.28%
Dolby Laboratories currently has a PE ratio of 40.30, a price-to-book (PB) ratio of 3.10, a price-to-sale (PS) ratio of 4.90, a price to cashflow ratio of 23.30, a PEG ratio of 2.52, a ROA of 6.92%, a ROC of 7.57% and a ROE of 8.28%. The company’s profit margin is 12.09%, its EBITDA margin is 26.80%, and its revenue ttm is $902.16 Million , which makes it $15.18 revenue per share.
Of the last four earnings reports from Dolby Laboratories, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.27 for the next earnings report. Dolby Laboratories’s next earnings report date is -.
The consensus rating of Wall Street analysts for Dolby Laboratories is Moderate Buy (1.75), with a target price of $93.67, which is +8.75% compared to the current price. The earnings rating for Dolby Laboratories stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Dolby Laboratories has a dividend yield of 1.45% with a dividend per share of $1.08 and a payout ratio of 29.00%.
Dolby Laboratories has a Buy technical analysis rating based on Technical Indicators (ADX : 8.14, ATR14 : 1.77, CCI20 : 21.27, Chaikin Money Flow : 0.31, MACD : 1.11, Money Flow Index : 56.65, ROC : -1.14, RSI : 55.93, STOCH (14,3) : 67.42, STOCH RSI : 0.42, UO : 60.39, Williams %R : -32.58), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Dolby Laboratories in the last 12-months were: Andy Sherman (Option Excercise at a value of $0), Andy Sherman (Sold 9 042 shares of value $630 563 ), Anjali Sud (Sold 17 746 shares of value $1 455 134 ), Avadis Tevanian (Sold 1 392 shares of value $116 427 ), Emily Rollins (Sold 1 000 shares of value $82 040 ), Gotcher Peter (Sold 6 288 shares of value $533 725 ), John D. Couling (Option Excercise at a value of $3 427 640), John D. Couling (Sold 87 360 shares of value $7 366 845 ), Kevin J. Yeaman (Option Excercise at a value of $4 201 424), Kevin J. Yeaman (Sold 92 339 shares of value $7 665 265 ), Mark Andrew Sherman (Option Excercise at a value of $1 839 795), Mark Andrew Sherman (Sold 61 910 shares of value $4 958 765 ), Pendleton Todd (Option Excercise at a value of $1 568 049), Pendleton Todd (Sold 35 590 shares of value $2 944 167 ), Peter Gotcher (Sold 6 288 shares of value $533 705 ), Rollins Emily (Sold 2 000 shares of value $166 740 ), Ryan Nicholson (Option Excercise at a value of $264 475), Ryan Nicholson (Sold 6 979 shares of value $590 122 ), Segars Simon (Sold 2 500 shares of value $211 325 ), Simon Segars (Sold 2 500 shares of value $211 319 ), Tevanian Avadis (Sold 1 392 shares of value $116 427 ), Todd Pendleton (Option Excercise at a value of $1 206 555), Todd Pendleton (Sold 28 701 shares of value $2 362 755 ), Yeaman Kevin (Option Excercise at a value of $8 858 737), Yeaman Kevin (Sold 200 699 shares of value $16 782 742 )
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.